MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

    B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)

  • Challenges with oral anti-parkinsonian medications and opportunities with continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) for treatment of advanced Parkinson’s Disease (aPD)

    J. Aldred, M. Soileau, C. Yan, T. Brion, A. Bellenger, J. Suh, C. O'Donnell, P. Kukreja, M. Facheris, A. Shewale, R. Kumar (Spokane, USA)

  • Change in quality of Life, depression, and lived experiences of women with Parkinson’s disease after deep drain stimulation

    MS. Kim, S. Jo, KW. Park, SH. Lee, YS. Hwang, SJ. Chung (Seoul, Republic of Korea)

  • Changes in artistic style and Parkinson’s Disease

    AM. Diezma Martín, G. Tabar Comellas, MI. Morales-Casado, DD. Garcia Melendez, JW. Ruiz Gómez, P. Quintana Castro, M. Ennazeh Elkhaili, D. Rivero Rodríguez, N. López Ariztegui (Toledo, Spain)

  • Changes in word fluency tasks and cognitive function before and after the COVID-19 epidemic in patients with Parkinson’s disease:PD.

    M. Sagawa, K. Hasegawa, A. Kumon, M. Saruwatari (Kanagawa, Japan)

  • Characterisation of OFF-Time in Levodopa-Treated Parkinson’s Patients: A Post-hoc Analysis of an Exploratory Trial

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, B. Guimarães, J-F. Rocha (Lisbon, Portugal)

  • Characterisation of the pharmacokinetic profile of L-DOPA in the common marmoset

    D. Bédard, F. Gaudette, F. Beaudry, P. Huot (Montreal, Canada)

  • Characteristics of cases in which stimulation was programmed for multiple targets in deep brain stimulation therapy for Parkinson’s disease.

    K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, F. Tanaka (Yokohama, Japan)

  • Characteristics of Huntington disease in a north Indian cohort

    D. Radhakrishnan, J. George, M. Faruq, R. Rajan, K. Kanojia, E. Arunmozhimaran, A. Das, A. Agarwal, A. Pandit, A. Srivastava (New Delhi, India)

  • Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale

    T. Roushdy, E. Hamid, H. Salem, S. Reda, A. Shalash (cairo, Egypt)

  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley